
Amgen
North America, California, United States, Thousand Oaks
Description
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
Investor Profile
Amgen has backed more than 18 startups, with 0 new investments in the last 12 months alone. The firm has led 7 rounds, about 39% of its total and boasts 8 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Corporate Round, Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in United States, Germany, Israel.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Series B (17%)
- Corporate Round (17%)
- Post Ipo Equity (11%)
- Non Equity Assistance (11%)
- Series Unknown (11%)
- Series E (11%)
- Series C (6%)
- Grant (6%)
- Post Ipo Debt (6%)
- Series A (6%)
Country Focus
- United States (78%)
- Germany (11%)
- Israel (6%)
- United Kingdom (6%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Health Diagnostics
- Enterprise Software
- Medical Device
- Analytics
- Data Integration
- Database
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.